- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-1 inhibitor
Total 105449 results
-
Denovo Biopharma LLCTerminatedSchizophreniaGermany, Spain, United States, Belgium, France, Sweden, Austria, Poland, Puerto Rico, Romania
-
Korea Otsuka Pharmaceutical Co., Ltd.CompletedSchizophrenia | Antipsychotics | Long-Acting Injection | LAI | AripiprazoleKorea, Republic of
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/S; PRA Health SciencesCompletedSchizophrenia | Bipolar I DisorderUnited States
-
University of Maryland, BaltimoreCompleted
-
Alkermes, Inc.CompletedSchizophreniaUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Duke UniversityCompletedAutism Spectrum DisorderUnited States
-
Hunan Cancer HospitalCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate Cancer
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarotid Artery Plaque | Pd-1 InhibitorsChina
-
Novartis PharmaceuticalsRecruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationItaly, Spain, United States, France, Thailand, Malaysia, China, Germany, India, Turkey, Belgium, Argentina, Bulgaria, Netherlands, Hungary, Greece, Portugal, Austria, Singapore, Brazil, United Kingdom
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
Second Affiliated Hospital of Soochow UniversitySciClone PharmaceuticalsRecruitingAdvanced Solid Tumor | Refractory TumorChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingStomach NeoplasmsChina, Japan, Poland, Turkey, Brazil, United States, Argentina, Australia, Canada, Chile, Colombia, Costa Rica, Czechia, Denmark, France, Germany, Guatemala, Hong Kong, Hungary, Ireland, Israel, Italy, Korea, Republic of, Mexico, New Zealand and more
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruiting
-
HotSpot Therapeutics, IncRecruitingSolid Tumor, Adult | Relapsed Cancer | Refractory CancerUnited States
-
Merck Sharp & Dohme LLCCompletedMelanomaAustralia, South Africa, Spain, Sweden
-
Fudan UniversityNot yet recruitingGastric Cancer | MSI-H | Adjuvant Therapy | PD-1 ImmunotherapyChina
-
Guoxin LiNot yet recruiting
-
Nanfang Hospital of Southern Medical UniversityRecruiting
-
Chinese PLA General HospitalRecruitingHodgkin Lymphoma | Anti-PD-1 Antibody ResistantChina
-
Merck Sharp & Dohme LLCTerminatedGastric Neoplasms | Gastroesophageal Junction AdenocarcinomaChina, Korea, Republic of, Malaysia, Taiwan
-
Merck Sharp & Dohme LLCCompleted
-
Peking UniversityNot yet recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Fudan UniversityRecruitingCarcinosarcoma | Sarcomatoid Carcinoma | PD-1 Immunotherapy | VEGFR-TKIChina
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
Fudan UniversityRecruiting
-
Coherus Biosciences, Inc.Shanghai Junshi Bioscience Co., Ltd.; Medpace, Inc.Active, not recruitingHepatocellular Carcinoma | Non-Small Cell Lung Cancer | Advanced Solid TumorUnited States
-
Dalian UniversityUnknownNon-small Cell Lung Cancer
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedLymphoma | Solid TumorsUnited States, Korea, Republic of, France, Israel, United Kingdom
-
23andMe, Inc.Michael J. Fox Foundation for Parkinson's Research; The Parkinson's InstituteCompleted
-
Merck Sharp & Dohme LLCCompletedNon-Small Cell Lung CancerUnited States, Canada, Hungary, Israel, Spain
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingBreast Cancer | Triple-Negative Breast CancerChina
-
Fukushima Medical UniversityKanagawa Cancer CenterUnknown
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
HutchmedBeiGeneActive, not recruitingSoft Tissue Sarcoma | Small Cell Lung Cancer | Gastric Cancer | Colorectal Cancer | Neuroendocrine Tumors | Metastatic Solid Tumor | Anaplastic Thyroid CancerUnited States
-
Greg Durm, MDMerck Sharp & Dohme LLC; Big Ten Cancer Research ConsortiumCompleted
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRecruitingStereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLCChina
-
China Meitan General HospitalMarino Biotechnology Co., Ltd.UnknownRecurrent PD-L1+ Malignant Tumors | Metastatic PD-L1+ Malignant TumorsChina
-
Merck Sharp & Dohme LLCTerminatedNeoplasmUnited States, Canada, Israel
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
Charitable Union for the Research and Education...Active, not recruitingVasectomy ReversalUnited States
-
Baylor Research InstituteCompleted